1Division of Pulmonary and Critical Care, University of Nevada School of Medicine, Las Vegas, NV. 2Department of Biostatistics, Johns Hopkins University, Baltimore, MD. 3Outcomes After Critical Illness and Surgery (OACIS) Group, Johns Hopkins University, Baltimore, MD. 4Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD. 5Department of Emergency Medicine, Chang Gung University and Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan 6Division of Pulmonary and Critical Care Medicine, University of Maryland, Baltimore, MD. 7Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, Baltimore, MD. 8Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD. 9Department of Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD.
Crit Care Med. 2014 Jun;42(6):1480-6. doi: 10.1097/CCM.0000000000000247.
Delirium is common in mechanically ventilated patients in the ICU and associated with short- and long-term morbidity and mortality. The use of systemic corticosteroids is also common in the ICU. Outside the ICU setting, corticosteroids are a recognized risk factor for delirium, but their relationship with delirium in critically ill patients has not been fully evaluated. We hypothesized that systemic corticosteroid administration would be associated with a transition to delirium in mechanically ventilated patients with acute lung injury.
Prospective cohort study.
Thirteen ICUs in four hospitals in Baltimore, MD.
Five hundred twenty mechanically ventilated adult patients with acute lung injury.
None.
Delirium evaluation was performed by trained research staff using the validated Confusion Assessment Method for the ICU screening tool. A total of 330 of the 520 patients (64%) had at least two consecutive ICU days of observation in which delirium was assessable (e.g., patient was noncomatose), with a total of 2,286 days of observation and a median (interquartile range) of 15 (9, 28) observation days per patient. These 330 patients had 99 transitions into delirium from a prior nondelirious, noncomatose state. The probability of transitioning into delirium on any given day was 14%. Using multivariable Markov models with robust variance estimates, the following factors (adjusted odds ratio; 95% CI) were independently associated with transition to delirium: older age (compared to < 40 years old, 40-60 yr [1.81; 1.26-2.62], and ≥ 60 yr [2.52; 1.65-3.87]) and administration of any systemic corticosteroid in the prior 24 hours (1.52; 1.05-2.21).
After adjusting for other risk factors, systemic corticosteroid administration is significantly associated with transitioning to delirium from a nondelirious state. The risk of delirium should be considered when deciding about the use of systemic corticosteroids in critically ill patients with acute lung injury.
在 ICU 中,机械通气患者中常见谵妄,且与短期和长期发病率和死亡率相关。全身性皮质类固醇的使用在 ICU 中也很常见。在 ICU 环境之外,皮质类固醇是谵妄的公认危险因素,但它们与重症患者谵妄的关系尚未得到充分评估。我们假设全身性皮质类固醇的给药与急性肺损伤机械通气患者谵妄的转变有关。
前瞻性队列研究。
马里兰州巴尔的摩的四所医院的 13 个 ICU。
520 名患有急性肺损伤的机械通气成年患者。
无。
通过经过培训的研究人员使用经过验证的 ICU 中使用的谵妄评估方法(即,患者非昏迷状态)对谵妄进行评估,共有 520 名患者中的 330 名(64%)有至少连续 2 天的 ICU 观察时间,可评估谵妄(例如,患者非昏迷状态),共有 2286 天的观察时间,每名患者的中位数(四分位距)为 15(9,28)观察日。这 330 名患者中有 99 名从先前非谵妄、非昏迷状态过渡到谵妄。任何一天出现谵妄的概率为 14%。使用具有稳健方差估计的多变量马尔可夫模型,以下因素(调整后的优势比;95%CI)与向谵妄转变独立相关:年龄较大(与<40 岁相比,40-60 岁[1.81;1.26-2.62],≥60 岁[2.52;1.65-3.87])和在过去 24 小时内给予任何全身性皮质类固醇(1.52;1.05-2.21)。
在调整其他危险因素后,全身性皮质类固醇的给药与从非谵妄状态向谵妄转变显著相关。在决定是否对患有急性肺损伤的重症患者使用全身性皮质类固醇时,应考虑谵妄的风险。